ZYVERSA THERAPEUTICS, INC. Investing Cash Flow
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Investing Cash Flow of -$2.70 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2022-11-14
- ZYVERSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2022-09-30 was $0.00.
- ZYVERSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2022-06-30 was $0.00.
- ZYVERSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2022-03-31 was -$2.70M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$2.70M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$2.70M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$2.70M 10-Q · filed 2022-05-13 | ||
| 2021-12-31 | -$75.75M 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |